HeartSciences raises $1.0M via PIPE to Fortitude at $2.43/share ahead of merger

HeartSciences Inc.

Sold 411,522 shares to Fortitude at $2.43/share, gross proceeds ~$1.0M.
Fortitude now holds ~9.4% of HeartSciences outstanding common stock.
Proceeds to fund operating expenses until closing of proposed merger with Fortitude (Merger Agreement dated June 23, 2026).
Shares issued in PIPE are not subject to Exchange Ratio under Merger Agreement.
Preliminary proxy statement for merger filed July 27, 2026; shareholder vote pending.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.